Pfizer Launches Cancer Drug Xalkori In Japan
This article was originally published in PharmAsia News
Executive Summary
Pfizer Inc. launched in Japan its precedent-setting lung-cancer drug Xalkori (crizotinib), which works by blocking genes that cause cancer.